Möchten Sie immer auf dem neuesten Stand bleiben?

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Nanopharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Medication Adherence Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Bags Aseptic Filling Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The 2025 iC³® Life Science & Healthcare Innovation Summit, hosted by BioNTX, concluded on September 16–17 at the Hilton Anatole in Dallas, marking more...

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Iron Deficiency Anemia Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ...

MannKind Announces U.S. FDA Accepts for Review its sNDA of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in adults with CHF or CKD

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years...

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility; Full Operational Capacity Expected by Year-End 2025 ...

Austin, TX, USA, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Yellow Phosphorus & Derivatives Market Size, Trends and Insights By...